Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Duodenal Neoplasms 1Colorectal Neoplasms 1Barrett Esophagus 1Attenuated familial adenomatous polyposis 1Adenomatous Polyposis Coli 1Adenocarcinoma Of Esophagus 1

Interventions

Pancreaticojejunostomy 4Endoscopic Mucosal Resection 3Octreotide 2obeticholic acid 1fludarabine 1apixaban 1aldesleukin 1X-Rays 1Ursodeoxycholic Acid 1Tranexamic Acid 1Tissue Adhesives 1Tea 1Surgical Procedures, Operative 1Stents 1Specimen Handling 1Sodium Chloride 1Rivaroxaban 1Radiotherapy 1Radiosurgery 1Phantoms, Imaging 1Pantoprazole 1Nutritional Status 1Nutrition Therapy 1Irinotecan 1Iopamidol 1Hydromorphone 1Hydrocortisone 1High-Energy Shock Waves 1Epinephrine 1Enteral Nutrition 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Duodenal Neoplasms × obeticholic acid × Gastrointestinal × Clear all
NCT05223036 2026-05-14

Testing Obeticholic Acid for Familial Adenomatous Polyposis

National Cancer Institute (NCI)

Phase 2 Terminated
15 enrolled
Gastrointestinal

Attenuated familial adenomatous polyposis, Duodenal Neoplasms, Adenomatous Polyposis Coli, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡